Clinical trial
Functional Coronary Angiography-Derived Index of Microcirculatory Resistance and Microvascular Obstruction in Cardiac Magnetic Resonance Imaging After ST-segment Elevation Myocardial Infarction
NCT04828681 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Functional Coronary Angiography-Derived Index of Microcirculatory Resistance and Microvascular Obstruction in Cardiac Magnetic Resonance Imaging After ST-segment Elevation Myocardial Infarction
- Lead sponsor
- Samsung Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 24, 2007
- Completion date
- December 31, 2023
- Enrollment
- 324 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
st-segment elevation myocardial infarction (stemi)